Compound: Ormeloxifene
SMILES: O1c2c(ccc(c2)OC)[C@@H](c3ccc(OCCN4CCCC4)cc3)[C@@H](C1(C)C)c5ccccc5
InChIKey: XZEUAXYWNKYKPL-WDYNHAJCSA-N
Synonyms: Ormeloxifene, CENTCHROMAN, Centron, Saheli, trans-Centchroman, 31477-60-8, 44AXY5VE90, Pyrrolidine, 1-(2-(4-(3,4-dihydro-7-methoxy-2,2-dimethyl-3-phenyl-2H-1-benzopyran-4-yl)phenoxy)ethyl)-, trans-, Ormeloxifeno, 1-(2-{4-[(3R,4R)-7-methoxy-2,2-dimethyl-3-phenyl-3,4-dihydro-2H-1-benzopyran-4-yl]phenoxy}ethyl)pyrrolidine, Compound 6720, Compound 67 20, ormeloxifenum, DTXCID901473968, 1-(2-(4-((3R,4R)-7-methoxy-2,2-dimethyl-3-phenyl-3,4-dihydro-2H-1-benzopyran-4-yl)phenoxy)ethyl)pyrrolidine, RefChem:856920, G03XC04, DTXSID6046844, Levormeloxifene, 78994-23-7, L-CentchroMan, (-)-centchroman, Levormeloxifene [INN], 78994-24-8, Ormeloxifene [INN], 1-[2-[4-[(3R,4R)-7-methoxy-2,2-dimethyl-3-phenyl-3,4-dihydrochromen-4-yl]phenoxy]ethyl]pyrrolidine, 6720-CDRI, (-)-1-(2-(4-((3R,4R)-7-Methoxy-2,2-dimethyl-3-phenyl-4-chromanyl)phenoxy)ethyl)pyrrolidine, 9512UKZ352, (- )-1-(2-(p-(trans-7-Methoxy-2,2-dimethyl-3-phenyl-4-chromanyl)phenoxy)ethyl)pyrrolidine, Compound 67/20, Centchroman-l, UNII-9512UKZ352, Choice 7, DTXSID301317017, 1-(2-(p-(trans-7-Methoxy-2,2-dimethyl-3-phenyl-4-chromanyl)phenoxy)ethyl)pyrrolidine, BRN 6075092, Centchroman (-)-form, CENTCHROMAN [MI], UNII-44AXY5VE90, ORMELOXIFENE [MART.], ORMELOXIFENE [WHO-DD], SCHEMBL107914, CHEMBL301327, orb1702034, LEVORMELOXIFENE [WHO-DD], CENTCHROMAN (-)-FORM [MI], BDBM50219398, AKOS032953987, DB13310, 1-(2-(4-((3R,4R)-7-methoxy-2,2-dimethyl-3-phenylchroman-4-yl)phenoxy)ethyl)pyrrolidine, 3,4-Trans-2,2-dimethyl-3-phenyl-4-(p-(beta-pyrrolidinoethoxy)-phenyl)-7-methoxychroman, 3,4-trans-2,2-Dimethyl-3-phenyl-4-(p-(beta-pyrrolidinoethoxy)phenyl)-7-methoxychroman, NNC-46-0020, Pyrrolidine, 1-(2-(p-(7-methoxy-2,2-dimethyl-3-phenyl-4-chromanyl)phenoxy)ethyl)-, trans-, trans-1-(2-(p-(7-Methoxy-2,2-dimethyl-3-phenyl-4-chromanyl)phenoxy)ethyl)pyrrolidine, trans-2,2-Dimethyl-3-phenyl-4-(p-(beta-pyrrolidinoethoxy)phenyl)-7-methoxychroman, Pyrrolidine, 1-(2-(4-(3,4-dihydro-7-methoxy-2,2-dimethyl-3-phenyl-2H-1-benzopyran-4-yl)phenoxy)ethyl)-, (3R-trans)-, HY-122359, CS-0084200, NS00126803, Q6535824, (+/-)-1-(2-(P-(TRANS-7-METHOXY-2,2-DIMETHYL-3-PHENYL-4-CHROMANYL)PHENOXY)ETHYL)PYRROLIDINE
Theoretical properties:
molecular_formula: C30H35NO3
molecular_weight: 457.6 g/mol
exact_mass: 457.26169398 g/mol
formal_charge: 0
hydrogen_bond_donor_count: 0
hydrogen_bond_acceptor_count: 4
rotatable_bond_count: 7
heavy_atom_count: 34
topological_polar_surface_area: 30.9 Å²
isotope_atom_count: 0
covalently_bonded_unit_count: 1
Physical properties:
Descriptions:
chembl: LEVORMELOXIFENE is a small molecule listed in the ChEMBL database and has reached clinical trial phase 2.0.
wikipedia: Ormeloxifene, also known as centchroman, is one of the selective estrogen receptor modulators, or SERMs, a class of medication which acts on the estrogen receptor. It is best known as a nonsteroidal oral contraceptive which is taken once per week.  In India, ormeloxifene has been available as birth control since the early 1990s, and it was marketed there under the trade name Saheli, currently available free-of-cost for the women in India as Chhaya (Centchroman).
Ormeloxifene has also been licensed under the trade names Ormalin, Novex-DS, Centron, and Sevista.